Innovent Biologics Inc
HKEX:1801

Watchlist Manager
Innovent Biologics Inc Logo
Innovent Biologics Inc
HKEX:1801
Watchlist
Price: 37 HKD -3.9% Market Closed
Market Cap: 60.6B HKD
Have any thoughts about
Innovent Biologics Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
Innovent Biologics Inc

Wall Street analysts forecast Innovent Biologics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Innovent Biologics Inc is 56.79 HKD with a low forecast of 32.42 HKD and a high forecast of 71.19 HKD.

Lowest
Price Target
32.42 HKD
12% Downside
Average
Price Target
56.79 HKD
53% Upside
Highest
Price Target
71.19 HKD
92% Upside
Innovent Biologics Inc Competitors:
Price Targets
SGMT
Sagimet Biosciences Inc
639% Upside
300142
Walvax Biotechnology Co Ltd
15% Downside
VRDN
Viridian Therapeutics Inc
108% Upside
MIRM
Mirum Pharmaceuticals Inc
43% Upside
VRTX
Vertex Pharmaceuticals Inc
17% Upside
OXB
Oxford BioMedica PLC
25% Upside

Revenue
Forecast

Revenue Estimate
Innovent Biologics Inc

For the last 6 years the compound annual growth rate for Innovent Biologics Inc's revenue is 164%. The projected CAGR for the next 3 years is 30%.

164%
Past Growth
30%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Innovent Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat

Net Income
Forecast

Net Income Estimate
Innovent Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
24%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Innovent Biologics Inc's stock price target?
Price Target
56.79 HKD

According to Wall Street analysts, the average 1-year price target for Innovent Biologics Inc is 56.79 HKD with a low forecast of 32.42 HKD and a high forecast of 71.19 HKD.

What is Innovent Biologics Inc's Revenue forecast?
Projected CAGR
30%

For the last 6 years the compound annual growth rate for Innovent Biologics Inc's revenue is 164%. The projected CAGR for the next 3 years is 30%.

Back to Top